NSW hires student doctors to ease pressure

November 27, 2022 01:52 PM AEDT | By AAPNEWS
Follow us on Google News:
Image source: AAPNEWS

More than 1000 NSW final-year medical students will be working in hospitals in paid positions to reduce pressure on hospitals in the state's latest bid to aid the system battered by COVID-19.

Premier Dominic Perrottet said the Assistant in Medicine (AiM) initiative was initially introduced in 2020 as a temporary workforce surge measure during the pandemic but it was so successful, it made sense for it to continue.

"This Australian-first program is good for students, good for hospital workers and it's great for patients," he told reporters on Sunday.

Mr Perrottet said the pilot program expanded from 400 part-time positions to 1100 final-year medical students who have been placed across regional and metropolitan hospitals as part of the state's $33 billion investment in health.

Regional Health Minister Bronnie Taylor said the program allows "medical students who are highly qualified ... to get into the system fast ... and to have a really significant role".

The announcement comes on the back of pharmacists being authorised by the government to administer a wider range of vaccinations. The Royal Australian College of General Practitioners slammed the move as "madness" and "a recipe for disaster" earlier this month.

Dr Jose Arguelles, who underwent the paid placement AiM program, said the initiative provides hands-on training and enables future doctors to navigate the health system by taking on patient care.

"You're given a set of responsibilities coming in day in and day out and learning about these patients - that's a privilege.

"It's a human job as well. We're not just robots," he said.

A Bureau of Health Information survey, released earlier this month, reported that NSW hospitals were less organised, their staff were not  working together effectively and the care being provided was not as good.

It asked more than 19,000 adult patients to rate the care they received throughout 202. The results showed worse outcomes than the 2020 survey.

More than one in five patients reported receiving contradictory information about their condition or how it would be treated.


The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

Top ASX Listed Companies

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK